| 000114 (2002) |
Joseph Jankovic [États-Unis] | Levodopa strengths and weaknesses |
| 000137 (2001) |
V Fraix [France] ; P Pollak ; N Van ; J Xie ; P Krack [Allemagne] ; A Koudsie ; A Benabid | Effect of subthalamic nucleus stimulation on levodopa-induced dyskinesia in Parkinson's disease |
| 000138 (2001) |
S Boyce [Royaume-Uni] ; N Rupniak [Royaume-Uni] ; M Steventon [Royaume-Uni] ; S Iversen [Royaume-Uni] | Differential effects of D1 and D2 agonists in MPTP-treated primates: Functional implications for Parkinson's disease |
| 000130 (2001) |
Y Agid [France] | Levodopa: Is toxicity a myth? |
| 000161 (2000) |
Joseph Jankovic [États-Unis] | Complications and limitations of drug therapy for Parkinson's disease |
| 000168 (1999) |
J Jankovic [États-Unis] ; E Lai [États-Unis] ; L Ben [États-Unis] ; J Krauss [États-Unis] ; R Grossman [États-Unis] | Levodopa-induced dyskinesias treated by pallidotomy |
| 000078 (2005) |
Katherine Widnell [États-Unis] ; Cynthia Comella [États-Unis] | Role of COMT inhibitors and dopamine agonists in the treatment of motor fluctuations |
| 000081 (2005) |
Cheryl Waters [États-Unis] | Other pharmacological treatments for motor complications and dyskinesias |
| 000084 (2005) |
Joseph Jankovic [États-Unis] | Motor fluctuations and dyskinesias in Parkinson's disease : Clinical manifestations |
| 000156 (2000) |
Joseph Jankovic [États-Unis] | Parkinson's disease therapy : Tailoring choices for early and late disease, young and old patients |
| 000190 (1995) |
M Mcdermott [États-Unis] ; J Jankovic ; J Carter ; S Fahn ; S Gauthier ; C Goetz ; L Golbe ; W Koller ; A Lang ; C Olanow ; I Shoulson ; M Stern ; C Tanner ; W Weiner | Factors predicitive of the need for levodopa therapy in early, untreated Parkinson's disease |
| 000058 (2007) |
Joseph Jankovic [États-Unis] ; Mark Stacy [États-Unis] | Medical management of levodopa-associated motor complications in patients with parkinson's disease |
| 000080 (2005) |
Katherine Widnell [États-Unis] | Pathophysiology of motor fluctuations in Parkinson's disease |
| 000083 (2005) |
C Olanow [États-Unis] ; Joseph Jankovic [États-Unis] | Neuroprotective therapy in Parkinson's disease and motor complications : A search for a pathogenesis-targeted, disease-modifying strategy |
| 000098 (2003) |
J Nutt [États-Unis] ; K Burchiel [États-Unis] ; C Comella [États-Unis] ; J Jankovic [États-Unis] ; A Lang [Canada] ; E Laws [États-Unis] ; A Lozano [Canada] ; R Penn [États-Unis] ; R Simpson [États-Unis] ; M Stacy [États-Unis] ; G Wooten [États-Unis] | Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD |
| 000111 (2002) |
M Ulivelli [Italie] ; S Rossi [Italie] ; C Lombardi [Italie] ; S Bartalini [Italie] ; R Rocchi [Italie] ; F Giannini [Italie] ; S Passero [Italie] ; N Battistini [Italie] ; E Lugaresi [Italie] ; David Rye [Italie] ; Joseph Jankovic [Italie] | Polysomnographic characterization of pergolide-induced sleep attacks in idiopathic PD. Editorial |
| 000119 (2001) |
| 50th anniversary reprint collection: Parkinson's disease |
| 000129 (2001) |
Lewis Doshay [États-Unis] ; Kate Constable | Newer drugs in the treatment of parkinsonism |
| 000135 (2001) |
N Giladi [États-Unis] ; M Mcdermott [États-Unis] ; S Fahn [États-Unis] ; S Przedborski [États-Unis] ; J Jankovic [États-Unis] ; M Stern [États-Unis] ; C Tanner [États-Unis] | Freezing of gait in PD: Prospective assessment in the datatop cohort |
| 000147 (2001) |
Wei Le [États-Unis] ; Joseph Jankovic [États-Unis] | Are dopamine receptor agonists neuroprotective in Parkinson's disease? |
| 000165 (1999) |
J Jankovic [États-Unis] | New and emerging therapies for Parkinson disease |
| 000171 (1999) |
W Le [États-Unis] ; D Rowe [États-Unis] ; J Jankovic [États-Unis] ; WENJIE XIE [États-Unis] ; S Appel [États-Unis] | Effects of cerebrospinal fluid from patients with Parkinson disease on dopaminergic cells |
| 000182 (1997) |
J Krauss [États-Unis] ; J Jankovic [États-Unis] ; E Lai [États-Unis] ; G Rettig [États-Unis] ; R Grossman [États-Unis] | Posteroventral medial pallidotomy in levodopa-unresponsive parkinsonism |
| 000191 (1994) |
J Jankovic ; I Shoulson ; W Weiner | Early-stage Parkinson's disease : to treat or not to treat |
| 000192 (1994) |
C Olanow [États-Unis] ; S Fahn ; M Muenter ; H Klawans ; H Hurtig ; M Stern ; I Shoulson ; R Kurlan ; J Grimes ; J Jankovic ; M Hoehn ; C Markham ; R Duvoisin ; O Reinmuth ; H Leonard ; E Ahlskog ; R Feldman ; L Hershey ; M Yahr | A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet® in Parkinson's disease |
| 000203 (1987) |
J Jankovic ; J Casabona | Coexistent tardive dyskinesia and parkinsonism |
| 000021 (2010) |
Fabrizio Stocchi [Italie] ; Olivier Rascol [France] ; Karl Kieburtz [États-Unis] ; Werner Poewe [Autriche] ; Joseph Jankovic [États-Unis] ; Eduardo Tolosa [Espagne] ; Paulo Barone [Italie] ; Anthony Lang [Canada] ; C Warren [États-Unis] | Initiating Levodopa/Carbidopa Therapy With and Without Entacapone in Early Parkinson Disease: The STRIDE-PD Study |
| 000064 (2006-11) |
J Jankovic | Current strategies in treating the Parkinson's disease patient |
| 000077 (2005) |
Leo Metman [États-Unis] ; Shaun O [États-Unis] | Role of surgery in the treatment of motor complications |
| 000100 (2003) |
Nicole Simpkins [États-Unis] ; Joseph Jankovic [États-Unis] | Neuroprotection in Parkinson disease |
| 000103 (2003) |
Madhavi Thomas [États-Unis] ; WEI DONG LE [États-Unis] ; Joseph Jankovic [États-Unis] | Minocycline and other tetracycline derivatives: A neuroprotective strategy in Parkinson's disease and Huntington's disease |
| 000112 (2002) |
William Ondo [États-Unis] ; Joel Levy [États-Unis] ; Kevin Dat [États-Unis] ; Christine Hunter [États-Unis] ; Joseph Jankovic [États-Unis] | Olanzapine treatment for dopaminergic-induced hallucinations |
| 000167 (1999) |
J Jankovic [États-Unis] ; L Ben [États-Unis] ; K Schwartz [États-Unis] ; KIM CHEN [États-Unis] ; M Khan [États-Unis] ; E Lai [États-Unis] ; J Krauss [États-Unis] ; R Grossman [États-Unis] | Movement and reaction times and fine coordination tasks following pallidotomy |
| 000170 (1999) |
W Ondo [États-Unis] ; C Hunter [États-Unis] ; M Almaguer [États-Unis] ; S Gancher [États-Unis] ; J Jankovic [États-Unis] | Efficacy and tolerability of a novel sublingual apomorphine preparation in patients with fluctuating Parkinson's disease |
| 000174 (1999) |
W Ondo [États-Unis] ; C Hunter [États-Unis] ; M Almaguer [États-Unis] ; J Jankovic [États-Unis] | A novel sublingual apomorphine treatment for patients with fluctuating Parkinson's disease |
| 000187 (1996) |
J Krauss [États-Unis] ; E Akeyson [États-Unis] ; P Giam ; J Jankovic | Propofol-induced dyskinesias in Parkinson's disease |
| 000194 (1993) |
F Cardoso [États-Unis] ; J Jankovic | Movement disorders |
| 000195 (1993) |
M Stacy [États-Unis] ; J Jankovic | Current approaches in the treatment of Parkinson's disease |
| 000200 (1989) |
J Jankovic ; K Schwartz ; C Vander | Comparison of Sinemet CR4 and standars Sinemet: double blind and long-term open trial in Parkinsonian patients with fluctuations |
| 000206 (1985) |
J Jankovic ; J Orman ; B Jansson | Placebo-controlled study of mesulergine in Parkinson's disease |
| 000208 (1985) |
J Jankovic | Long-term use of dopamine agonists in Parkinson's disease |
| 000000 (2012) |
Andrew Lees [Royaume-Uni] ; Stanley Fahn [États-Unis] ; Karla Eggert [Allemagne] ; Joseph Jankovic [États-Unis] ; Anthony Lang [Canada] ; Federico Micheli [Argentine] ; M Maral [États-Unis] ; Wolfgang Oertel [Allemagne] ; C Olanow [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Eduardo Tolosa [Espagne] ; David Squillacote [États-Unis] ; Dinesh Kumar [États-Unis] | Perampanel, an AMPA Antagonist, Found to Have No Benefit in Reducing "Off" Time in Parkinson's Disease |
| 000001 (2012) |
Brad Racette [États-Unis] ; Michael Aschner [États-Unis] ; Tomas Guilarte [États-Unis] ; Ulrike Dydak [États-Unis] ; Susan Criswell [États-Unis] ; WEI ZHENG [États-Unis] | Pathophysiology of manganese-associated neurotoxicity |
| 000011 (2011) |
Joseph Jankovic [États-Unis] | Diagnosis and treatment of psychogenic parkinsonism |
| 000012 (2011) |
José Baizabal [États-Unis] ; Richard Simpson [États-Unis] ; Joseph Jankovic [États-Unis] | Diagnosis and Treatment of Complications Related to Deep Brain Stimulation Hardware |
| 000035 (2009) |
Joseph Jankovic [États-Unis] | Disease-oriented approach to botulinum toxin use |
| 000037 (2009) |
C Olanow [États-Unis] ; Olivier Rascol [France] ; Robert Hauser [États-Unis] ; Paul Feigin [Israël] ; Joseph Jankovic [États-Unis] ; Anthony Lang [Canada] ; William Langston [États-Unis] ; Eldad Melamed [Israël] ; Werner Poewe [Autriche] ; Fabrizio Stocchi [Italie] ; Eduardo Tolosa [Espagne] | A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease |
| 000046 (2008) |
M York [États-Unis] ; M Dulay [États-Unis] ; A Macias [États-Unis] ; H Levin [États-Unis] ; R Grossman [États-Unis] ; R Simpson [États-Unis] ; J Jankovic [États-Unis] | Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson's disease |
| 000050 (2008) |
C Olanow [États-Unis] ; Robert Hauser [États-Unis] ; Joseph Jankovic [États-Unis] ; William Langston [États-Unis] ; Anthony Lang [Canada] ; Wemer Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Fabrizio Stocchi [Italie] ; Eldad Melamed [Israël] ; Eli Eyal [Israël] ; Olivier Rascol [France] | A Randomized, Double-Blind, Placebo-Controlled, Delayed Start Study to Assess Rasagiline as a Disease Modifying Therapy in Parkinson's Disease (The ADAGIO Study) : Rationale, Design, and Baseline Characteristics |
| 000054 (2007) |
Christopher Kenney [États-Unis] ; Richard Simpson [États-Unis] ; Christine Hunter [États-Unis] ; William Ondo [États-Unis] ; Michael Almaguer [États-Unis] ; Anthony Davidson [États-Unis] ; Joseph Jankovic [États-Unis] | Short-term and long-term safety of deep brain stimulation in the treatment of movement disorders |
| 000079 (2005) |
Ron Tintner [États-Unis] ; Prasad Manian [États-Unis] ; Polly Gauthier [États-Unis] ; Joseph Jankovic [États-Unis] | Pleuropulmonary fibrosis after long-term treatment with the dopamine agonist pergolide for Parkinson disease |
| 000088 (2005) |
Shaheda Azher [États-Unis] ; Joseph Jankovic [États-Unis] | Camptocormia : Pathogenesis, classification, and response to therapy |
| 000094 (2004) |
Markus Naumann [Allemagne] ; Wolfgang Jost [Allemagne] | Botulinum toxin treatment of secretory disorders |
| 000099 (2003) |
TIANHONG PAN [États-Unis] ; Joseph Jankovic [États-Unis] ; WEIDONG LE [États-Unis] | Potential therapeutic properties of green tea polyphenols in Parkinson's disease |
| 000121 (2001) |
Philippe Damier [France] ; Jean Houeto [France] ; Boulos Bejjani [Liban] ; Isabelle Arnulf [France] ; Anne Bonnet [France] ; Malika Miloudy [France] ; Yves Agid [France] | The role of the pallidum in Parkinson's disease: Gait lessons from pallidal stimulation |
| 000122 (2001) |
William Ondo [États-Unis] ; Kevin Dat [États-Unis] ; Michael Almaguer [États-Unis] ; Joseph Jankovic [États-Unis] ; Richard Simpson [États-Unis] | Thalamic deep brain stimulation: Effects on the nontarget limbs |
| 000123 (2001) |
William Ondo [États-Unis] ; Michael Almaguer [États-Unis] ; Joseph Jankovic [États-Unis] ; Richard Simpson [États-Unis] | Thalamic deep brain stimulation: Comparison between Unilateral and Bilateral placement |
| 000124 (2001) |
P Hanna [États-Unis] ; L Ratkos [États-Unis] ; W Ondo [États-Unis] ; J Jankovic [États-Unis] | Switching from pergolide to pramipexole in patients with Parkinson's disease |
| 000131 (2001) |
Meg Morris [Australie] ; Frances Huxham [Australie] ; Jennifer Mcginley [Australie] ; Robert Iansek [Australie] | Gait disorders and gait rehabilitation in Parkinson's disease |
| 000136 (2001) |
Joseph Jankovic [États-Unis] ; Eugene Lai [États-Unis] ; William Ondo [États-Unis] ; Deborah Roberts [États-Unis] ; Sharon Olson [États-Unis] ; Joachim Krauss [Allemagne] ; Robert Grossman [États-Unis] | Effects of pallidotomy on gait and balance |
| 000145 (2001) |
Francesc Valldeoriola [Espagne] ; José Molinuevo [Espagne] ; Josep Valls [Espagne] | Bilateral subthalamic stimulation and parkinsonian gait |
| 000150 (2000) |
W Ondo [États-Unis] ; L Ben [États-Unis] ; J Jankovic [États-Unis] ; E Lai [États-Unis] ; C Contant [États-Unis] ; R Grossman [États-Unis] | Weight gain following unilateral pallidotomy in Parkinson's disease |
| 000153 (2000) |
L Zou [États-Unis] ; JING XU [États-Unis] ; J Jankovic [États-Unis] ; YI HE [États-Unis] ; S Appel [États-Unis] ; W Le [États-Unis] | Pramipexole inhibits lipid peroxidation and reduces injury in the substantia nigra induced by the dopaminergic neurotoxin 1-methyl- phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice |
| 000154 (2000) |
Deborah Roberts [États-Unis] ; Averell Overby [États-Unis] ; Joseph Jankovic [États-Unis] ; Sharon Olson [États-Unis] ; Eugene Lai [États-Unis] ; J Krauss [États-Unis] ; Robert Grossman [États-Unis] | Postural control in Parkinson's disease after unilateral posteroventral pallidotomy |
| 000166 (1999) |
P Hanna [États-Unis] ; J Jankovic [États-Unis] ; J Kirkpatrick [États-Unis] | Multiple system atrophy : The putative causative role of environmental toxins |
| 000181 (1997) |
J Jankovic [États-Unis] ; W Hamilton [États-Unis] ; R Grossman [États-Unis] | Thalamic surgery for movement disorders |
| 000189 (1995) |
J Jankovic [États-Unis] ; F Cardoso [États-Unis] ; R Grossman ; W Hamilton ; R Tasker ; P Kelly | Outcome after stereotactic thalamotomy for Parkinsonian, essential, and other types of tremor. Commentaries |
| 000201 (1989) |
J Jankovic ; R Grossman ; C Goodman ; F Firozzolo ; L Schneider ; Z Zhu ; P Scardino ; A Garber ; S Jhingran ; S Martin | Clinical, biochemical, and neuropathologic findings following transplantation of adrenal medulla to the caudate nucleus for treatment of Parkinson's disease |
| 000209 (1985) |
J Jankovic | Long-term study of pergolide in Parkinson's disease |
